Join Drs. Glesby and Stein as they review evidence for managing HIV-infected patients with dyslipidemia-should one switch antiretroviral therapy or add lipid-lowering agents?
Registration for this activity is open to physicians and healthcare professionals actively involved in the delivery of care to HIV-infected patients. Other restrictions may apply.
| Event Date | Details | |
|---|---|---|
| Monday, June 30, 2008 | 8:00 PM - 9:00 PM EDT | |
| Tuesday, July 15, 2008 | 11:00 AM - 12:00 PM EDT | |
| Thursday, July 17, 2008 | 3:00 PM - 4:00 PM EDT |
Introduction and CME Information (5 minutes)
Managing Dyslipidemia by Switching Antiretroviral Therapy (20 minutes)
Marshall J. Glesby, MD, PhD
Managing Dyslipidemia by Adding Lipid-Lowering Agents (20 minutes)
James H. Stein, MD
Case Studies Questions From Teleconference Attendees (15 minutes)
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

There are no fees required to participate in this educational activity